PubMed Health⌕ Search

PubMed · 2559268

[Bowenoid papulosis].

Abstract

Bowenoid papulosis is a clinical-histopathologic entity described in the last ten years. The appearance and publication of an increasing number of cases in the world literature and the advances in laboratory techniques for detection of papilloma-virus, lead to a better knowledge of its clinical picture, etiology, prognosis and therapy. Upon this basis, a therapeutic and clinical approach is suggested.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Lobos Bert. 1989. [Bowenoid papulosis].. https://pubmed.ncbi.nlm.nih.gov/2559268/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

DNase1L2 degrades nuclear DNA during corneocyte formation.

The removal of keratinocyte (KC) nuclear DNA by deoxyribonucleases (DNases) is an important step in the formation of normal stratum corneum (SC). However, the molecular identity of the DNA-degrading enzymes has so far remained elusive. Here we show that the endonuclease DNase1-like 2 (DNase1L2) is preferentially expressed in the epidermis and that its expression correlates with terminal differentiation of KC in vitro and in vivo. In biopsies of normal skin, DNase1L2 mRNA was regularly found in suprabasal KC and DNase1L2 protein was highly abundant in the stratum granulosum. In contrast to normal skin, DNase1L2 expression was downregulated in parakeratotic epidermis such as in psoriatic lesions. When DNase1L2 gene expression was knocked down by small interfering RNA in a human skin equivalent model, nuclei were maintained through all layers of the SC. Taken together, our data demonstrate that DNase1L2 plays an essential role in DNA degradation during terminal differentiation of epidermal KC.

Bowen's Disease↗